Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-(4-((4-chloro-3-(trifluoromethyl)phenyl)sulfonyl)phenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione |
---|---|
Date Designated: | 08/08/2019 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Neuropore Therapies, Inc. 10835 Road to the Cure, Suite 230 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-